Winnergy Medical PCL (BKK:WINMED)

Market Cap	460.00M -15.4%
Revenue (ttm)	699.71M +2.6%
Net Income	16.79M -47.0%
EPS	0.04 -47.0%
Shares Out	400.00M
PE Ratio	27.40
Forward PE	n/a
Dividend	0.01 (1.23%)
Ex-Dividend Date	Mar 16, 2026

Volume	355,600
Open	1.160
Previous Close	1.170
Day's Range	1.130 - 1.180
52-Week Range	0.690 - 1.460
Beta	0.20
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Winnergy Medical PCL

Winnergy Medical Public Company Limited engages in the distribution of medical and diagnostic equipment in Thailand. The company imports and distributes technology and diagnostic kits for cervical cancer screening, including cytology examinations using automatic slide preparation machines and testing for human papilloma virus, and colposcopes. It also offers equipment for testing blood quality and blood collection bags for blood donation; blood quality testing products; blood freezers; blood banking, including pathogen inactivation; blood bag t...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2004
• Employees: 146
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: WINMED

Financial Performance

In 2025, Winnergy Medical PCL's revenue was 647.04 million, a decrease of -1.12% compared to the previous year's 654.36 million. Earnings were 15.17 million, a decrease of -48.15%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 3, 2026

Data Sources Report a data error